JOURNAL OF CLINICAL SURGERY ›› 2025, Vol. 33 ›› Issue (2): 210-212.doi: 10.3969/j.issn.1005-6483.20240436

Previous Articles     Next Articles

Research progress of immunotherapy in neoadjuvant therapy of esophageal cancer

  

  1. Department of Thoracic Surgery,the Second Affiliated Hospital of Shandong First Medical University,Taian,Shandong 271000,China
  • Online:2025-02-20 Published:2025-02-20

Abstract: Esophageal cancer (EC) is most commonly diagnosed in our country as an advanced esophageal cancer.With the continuous exploration and innovation of treatment methods,the comprehensive treatment scheme based on surgery is gradually improved.Immunotherapy is a new way to treat tumors in recent years.How to make better use of it in neoadjuvant therapy to create a better prognosis for EC is worth discussing.

Key words: esophageal cancer, neoadjuvant therapy, immunotherapy

[1] KANG Shuhong, LYU Feng, NI Yunfeng, YUN Junru. Clinical value of miR-27a and miR-1299 in predicting  prognosis of patients with esophageal cancer [J]. JOURNAL OF CLINICAL SURGERY, 2024, 32(8): 803-806.
[2] WANG Jichao, XUE Junying, ZHANG Jianhua, YANG Jin, WANG Linpei. The effect of improved total cavity endoscopy on lung function,postoperative feeding and complications in patients with chronic lung disease of esophageal cancer [J]. JOURNAL OF CLINICAL SURGERY, 2024, 32(8): 807-810.
[3] CHEN Hainan, LENG Xuefeng. Research Progress on Predictive Factors and Related Predictive Models for Anastomotic Leakage After Esophageal Cancer Surgery [J]. JOURNAL OF CLINICAL SURGERY, 2024, 32(8): 892-895.
[4] WANG Qing, CHEN Lili, LIU Yupeng. Establishment and application of a nomogram model for predicting the risk of cervical anastomotic leakage after esophagectomy of esophageal cancer [J]. JOURNAL OF CLINICAL SURGERY, 2024, 32(7): 716-720.
[5] LIU Shengkai,CUI Lina,LI Junpeng,SHI Junjie,FAN Yanling. Effect of surgical approach on complications and tumor marker levels in patients undergoing radical resection of esophageal cancer [J]. JOURNAL OF CLINICAL SURGERY, 2024, 32(6): 603-606.
[6] HUANG Hongwei,CHEN Qi,LIAO Wei,ZHANG Kaiyue,WANG Hao,MEI Bin. Postoperative adjuvant immunotherapy for huge hepatocellular carcinoma in China liver cancer staging Ⅲa [J]. JOURNAL OF CLINICAL SURGERY, 2024, 32(4): 386-390.
[7] HUANG Xiaomei,GUO Ming,LUO Junlong,BAO Chuan’en,HU Meng. Study on the relationship between serum levels of vascular endothelial growth factor and insulin-like growth factor-1 and esophagogastric anastomotic fistula in patients after thoracoscopic radical resection of esophageal cancer [J]. JOURNAL OF CLINICAL SURGERY, 2024, 32(3): 276-280.
[8] ZHAO Tianhao, ZHAO Chun. Survival prognosis of multiple malignant tumors with secondary primary esophageal cancer:a population-based analysis [J]. JOURNAL OF CLINICAL SURGERY, 2024, 32(2): 158-163.
[9] JIANG Fan, XIE Keqi. Impacts of butorphanol on the proliferation,apoptosis and migration of esophageal cancer cells by regulating CCL2-CCR2 axis [J]. JOURNAL OF CLINICAL SURGERY, 2024, 32(2): 168-172.
[10] YANG Cuiying, ZHAO Zheng, ZHANG Liangliang, JIN Zhao. Expression of MiR-33a-5p and SIRT6 in the serum of esophageal cancer patients and their relationship with clinical pathological characteristics [J]. JOURNAL OF CLINICAL SURGERY, 2024, 32(11): 1147-1151.
[11] ZHU Ronghua, HUANG Zhiyong. Advancements in the treatment of malignancies using a combination of immune checkpoint inhibitors and immunomodulators [J]. JOURNAL OF CLINICAL SURGERY, 2024, 32(1): 92-95.
[12] LI Dawei, XIA Shihui. Influencing factors of disease-free survival in patients with stage Ⅲ non-small cell lung cancer after neoadjuvant chemotherapy combined with immunotherapy [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(7): 626-629.
[13] CHEN Taoyu, WU Heshui. Current status and challenges of neoadjuvant therapy for pancreatic cancer [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(7): 694-697.
[14] CHENG Dongliang, LIN Chengyi, GUO Jialong, LIU Huasong, LIU Hua.. The influence of different cervical anastomosis methods on complications during laparoscopic esophageal cancer surgery [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(12): 1156-1159.
[15] LONG Xinglin, XIE Songping, LIU Gaoli, ZHang Wenhan, HUANG Jie. Clinical efficacy of immunotherapy combined with chemotherapy sequential surgery for locally advanced esophageal cancer [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(11): 1040-1043.
Viewed
Full text
30
HTML PDF
Just accepted Online first Issue Just accepted Online first Issue
0 0 0 0 0 30

  From local
  Times 30
  Rate 100%

Abstract
61
Just accepted Online first Issue
0 0 61
  From Others local
  Times 59 2
  Rate 97% 3%

Cited

Web of Science  Crossref   ScienceDirect  Search for Citations in Google Scholar >>
 
This page requires you have already subscribed to WoS.
  Shared   
  Discussed   
[1] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 737 .
[2] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 747 .
[3] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 750 .
[4] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 753 .
[5] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 766 .
[6] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 772 .
[7] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 783 .
[8] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 802 .
[9] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 808 .
[10] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 809 .